Establishes the process to provide a legal mechanism whereby a terminally ill patient may choose to end their life using medications prescribed by a physician.
H5219, titled the Lila Manfield Sapinsley Compassionate Care Act, would create a new chapter in Rhode Island law authorizing a process for certain terminally ill adult residents to obtain medication from a physician to self-administer for the purpose of hastening death. The bill sets out detailed eligibility and procedural safeguards, including a terminal condition prognosis of six months or less, a bona fide physician-patient relationship, oral and written requests, waiting periods, witness requirements, confirmation of capacity and informed decision-making, and consultation with a second physician and, when needed, a mental health professional.
The bill also requires physicians to document each step in the patient’s medical record and report completion to the Department of Health. It expressly preserves the right of healthcare providers and facilities to refuse participation, allows facilities to prohibit on-site use under certain conditions, and states that the act does not authorize euthanasia, mercy killing, or lethal injection. It further addresses immunity, insurance protections, palliative care disclosures, and safe disposal of unused medication.
If enacted, the bill would add a new end-of-life option to Title 23 of the Rhode Island General Laws and would create legal protections and procedural duties for physicians who comply with the act. It would also affect healthcare facilities, pharmacists, insurers, and family members by defining when participation is voluntary, limiting liability for good-faith compliance, and prohibiting denial of life insurance benefits or adverse malpractice insurance treatment based solely on participation or nonparticipation. The Department of Health would be required to adopt rules for disposal of unused medications, and the act would take effect immediately upon passage.
No committee transcripts or recorded votes were provided, so there is no direct evidence of debate or formal sentiment from the legislative process in the supplied materials. Based on the bill text and caption, the measure appears to be framed as a carefully regulated patient-choice and compassionate-care proposal, with extensive safeguards intended to address medical, ethical, and legal concerns. The absence of recorded votes or hearing testimony means the overall political sentiment cannot be determined from the provided record.
The main points of contention likely concern physician-assisted death itself, including whether the state should permit medication intended to hasten death, how to ensure voluntariness and decisional capacity, and whether the safeguards are sufficient to prevent coercion or abuse. Potential opponents may focus on moral, religious, disability-rights, or end-of-life ethics objections, while supporters are likely to emphasize patient autonomy, relief of suffering, and terminal illness choice. The bill also anticipates institutional objections by preserving provider refusal rights and allowing healthcare facilities to restrict on-premises use, suggesting tension between patient access and institutional conscience or policy concerns.